Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Modulators of drug/multidrug resistance from Lilly

June 29, 1998

Tricyclic antitumor compounds developed at Schering-Plough

June 29, 1998

New class of FPTase inhibitors discovered at Merck & Co.

June 29, 1998

Melphalan derivative pinpointed for further study

June 29, 1998

rAd-p53 in gene therapy of cancers with p53 mutation; overview of gene therapies in development

June 29, 1998

Potential use of BSH in boron neutron capture therapy evaluated in clinical trials

June 26, 1998

U.K. investigators identify interesting candidate for clinical evaluation

June 26, 1998

French investigators evaluate potential cell-free antitumor vaccine

June 26, 1998

German scientists synthesize novel apoptosis-inducing agents

June 26, 1998

Verapamil prodrug enhances activity of cytotoxic agents in resistant cell lines

June 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...